Effective formation by thyroid epithelial cells of MHC Class II-peptide complexes derived from endogenous antigen by thyroid epithelial cells

R Maile, KA Elsegood, TC Harding, JB Uney, GS Banting, CM Dayan

Research output: Contribution to journalArticle (Academic Journal)peer-review

8 Citations (Scopus)

Abstract

In autoimmune thyroid disease, thyroid epithelial cells (TEC) express major histocompatibility complex (MHC) class II molecules, potentially enabling them to present thyroid self-antigens to CD4-positive T cells. However, despite this, TEC may fail to present endogenous antigen as a result of limited processing or MHC class II loading capacity, or inadequate MHC class II levels. We addressed these issues using the cloned rat TEC line, Fischer rat thyroid cell line (FRTL5), which was transfected using an adenoviral expression vector that expressed ovalbumin (OVA) as an integral membrane protein. OVA-expressing FRTL5 cells very efficiently activated a panel of OVA-specific, class II-restricted T-cell hybridomas. This response was dependent on induction of MHC class II molecules by interferon-γ (IFN-γ) and was blocked by anti-MHC class II antibodies. Poor responses were seen to exogenously added OVA or OVA peptides. These results provide the most direct evidence to date that TEC can form MHC class II–peptide complexes derived from self-antigen in sufficient quantities to activate T cells.
Translated title of the contributionEffective formation by thyroid epithelial cells of MHC Class II-peptide complexes derived from endogenous antigen
Original languageEnglish
Pages (from-to)367-374
Number of pages8
JournalImmunology
Volume99
Issue number3
DOIs
Publication statusPublished - Mar 2000

Fingerprint Dive into the research topics of 'Effective formation by thyroid epithelial cells of MHC Class II-peptide complexes derived from endogenous antigen by thyroid epithelial cells'. Together they form a unique fingerprint.

Cite this